JP2013006854A5 - - Google Patents

Download PDF

Info

Publication number
JP2013006854A5
JP2013006854A5 JP2012191753A JP2012191753A JP2013006854A5 JP 2013006854 A5 JP2013006854 A5 JP 2013006854A5 JP 2012191753 A JP2012191753 A JP 2012191753A JP 2012191753 A JP2012191753 A JP 2012191753A JP 2013006854 A5 JP2013006854 A5 JP 2013006854A5
Authority
JP
Japan
Prior art keywords
halogen atom
alkyl group
thio
hydrogen atom
glucitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012191753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013006854A (ja
JP5660094B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012191753A priority Critical patent/JP5660094B2/ja
Priority claimed from JP2012191753A external-priority patent/JP5660094B2/ja
Publication of JP2013006854A publication Critical patent/JP2013006854A/ja
Publication of JP2013006854A5 publication Critical patent/JP2013006854A5/ja
Application granted granted Critical
Publication of JP5660094B2 publication Critical patent/JP5660094B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012191753A 2009-04-16 2012-08-31 併用医薬 Expired - Fee Related JP5660094B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012191753A JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009100210 2009-04-16
JP2009100210 2009-04-16
JP2012191753A JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011540651A Division JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014245257A Division JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬

Publications (3)

Publication Number Publication Date
JP2013006854A JP2013006854A (ja) 2013-01-10
JP2013006854A5 true JP2013006854A5 (https=) 2013-05-30
JP5660094B2 JP5660094B2 (ja) 2015-01-28

Family

ID=42982643

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2011540651A Active JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬
JP2012191753A Expired - Fee Related JP5660094B2 (ja) 2009-04-16 2012-08-31 併用医薬
JP2014245257A Active JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬
JP2015253932A Active JP6066144B2 (ja) 2009-04-16 2015-12-25 併用医薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2011540651A Active JP5077786B2 (ja) 2009-04-16 2010-04-16 併用医薬

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014245257A Active JP5910711B2 (ja) 2009-04-16 2014-12-03 併用医薬
JP2015253932A Active JP6066144B2 (ja) 2009-04-16 2015-12-25 併用医薬

Country Status (30)

Country Link
US (1) US20120040898A1 (https=)
EP (3) EP2419097B1 (https=)
JP (4) JP5077786B2 (https=)
KR (2) KR20120016051A (https=)
CN (7) CN102395364A (https=)
AR (1) AR076317A1 (https=)
AU (1) AU2010237748B2 (https=)
BR (1) BRPI1012539A2 (https=)
CA (1) CA2755392A1 (https=)
CY (2) CY1114703T1 (https=)
DK (2) DK2601949T3 (https=)
ES (2) ES2523408T3 (https=)
HK (6) HK1217301A1 (https=)
HR (2) HRP20131120T1 (https=)
ME (2) ME02015B (https=)
MX (1) MX2011010901A (https=)
MY (3) MY183793A (https=)
NZ (4) NZ606888A (https=)
PH (3) PH12015500235A1 (https=)
PL (2) PL2601949T3 (https=)
PT (2) PT2601949E (https=)
RS (2) RS53056B (https=)
RU (2) RU2532330C2 (https=)
SG (6) SG2014015093A (https=)
SI (2) SI2601949T1 (https=)
SM (1) SMT201500015B (https=)
TW (3) TW201103534A (https=)
UA (2) UA111742C2 (https=)
WO (1) WO2010119990A1 (https=)
ZA (1) ZA201106727B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772191B2 (en) 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
AP2011005795A0 (en) 2009-02-13 2011-08-31 Boehringer Ingelheim Int SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia.
JP5758900B2 (ja) 2009-09-30 2015-08-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング グルコピラノシル置換ベンジルベンゼン誘導体の調製方法
UY32919A (es) 2009-10-02 2011-04-29 Boehringer Ingelheim Int Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
US20120283169A1 (en) * 2010-11-08 2012-11-08 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
TR201101809A1 (tr) * 2010-12-21 2012-07-23 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Vildagliptin ve glimepirid kombinasyonları.
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
HK1202458A1 (en) 2012-05-17 2015-10-02 Vtv治疗有限责任公司 Glucokinase activator compositions for the treatment of diabetes
US9320727B2 (en) * 2012-08-30 2016-04-26 Taisho Pharmaceutical Co., Ltd Combinations of SGLT 2 inhibitors and antihypertensive drugs
HRP20190101T1 (hr) 2013-04-05 2019-03-08 Boehringer Ingelheim International Gmbh Terapeutske uporabe empagliflozina
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CA2812519A1 (en) 2013-04-05 2014-10-05 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
FI4000608T3 (fi) 2013-04-18 2026-01-21 Boehringer Ingelheim Int Farmaseuttinen koostumus, menetelmä hoitamiseksi ja sen käyttöjä
TW201636015A (zh) * 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物
JP6467583B2 (ja) * 2015-02-27 2019-02-13 ジ アサン ファウンデーション Dpp−4の抑制剤を含む弁膜石灰化の予防または治療用の組成物
CN105963280B (zh) * 2016-06-30 2018-11-06 合肥华方医药科技有限公司 一种伏格列波糖口腔速溶膜及其制备方法
BR112019005930A2 (pt) 2016-10-19 2019-06-11 Boehringer Ingelheim Int combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
KR20250097990A (ko) 2016-11-10 2025-06-30 베링거 인겔하임 인터내셔날 게엠베하 약제학적 조성물, 치료 방법 및 이의 용도
US11439689B2 (en) * 2016-11-14 2022-09-13 Kaohsiung Medical University Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor
US20210113561A1 (en) 2018-04-17 2021-04-22 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
KR20190137343A (ko) 2018-06-01 2019-12-11 김유찬 계량 인덕션
CN112040945A (zh) 2018-06-12 2020-12-04 Vtv治疗有限责任公司 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
US12213970B2 (en) 2018-10-29 2025-02-04 Boehringer Ingelheim International Gmbh Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
DK3873600T5 (da) 2018-10-29 2024-03-18 Boehringer Ingelheim Int Pyridinylsulfonamidderivater, farmaceutiske sammensætninger og anvendelser deraf
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4432757A1 (de) 1994-09-14 1996-03-21 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
JP2003520759A (ja) 1999-08-31 2003-07-08 アンドルックス ファーマスーティカルズ インコーポレーテッド 単位核を有する徐放性錠剤
WO2002080936A1 (en) * 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
WO2002083066A2 (en) * 2001-04-11 2002-10-24 Bristol-Myers Squibb Company Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
TW200637839A (en) * 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives
RU2434862C2 (ru) * 2006-06-29 2011-11-27 Тайсо Фармасьютикал Ко., Лтд. С-фенил-1-тиоглюцитолы
JP5194588B2 (ja) * 2006-07-06 2013-05-08 大正製薬株式会社 1−チオ−d−グルシトール誘導体を有効成分として含有する糖尿病の予防又は治療剤
CA2656847A1 (en) * 2006-08-15 2008-02-21 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture
AU2007316613B2 (en) * 2006-11-09 2013-11-28 Boehringer Ingelheim International Gmbh Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
AU2007332476A1 (en) * 2006-12-14 2008-06-19 Taisho Pharmaceutical Co., Ltd. 1-phenyl 1-thio-D-glucitol derivative
PE20090938A1 (es) 2007-08-16 2009-08-08 Boehringer Ingelheim Int Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
PE20090603A1 (es) 2007-08-16 2009-06-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de sglt2 y un inhibidor de dpp iv

Similar Documents

Publication Publication Date Title
JP2013006854A5 (https=)
RU2011146335A (ru) Фармацевтические композиции
EP2275108B1 (en) Pharmaceutical preparation comprising dpp-iv inhibitor and other diabetes therapeutic agent in concomitant or combined form
US9487508B2 (en) SGC stimulators
JP2011504903A5 (https=)
JP2008007519A5 (https=)
JP2018502101A5 (https=)
CY1116799T1 (el) Προληψη της υπογλυκαιμιας σε ασθενεις με σακχαρωδη διαβητη τυπου 2
CA2789665A1 (en) Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
JP2011509922A5 (https=)
JP2014500295A5 (https=)
JP2012533546A5 (https=)
JP2005506352A5 (https=)
CY1113755T1 (el) Η λιξισενατιδη ως επιπροσθετη αγωγη στην ινσουλινη γλαργινη και στη μετφορμινη για τη θεραπευτικη αντιμετωπιση του διαβητη τυπου 2
JP2018504393A5 (https=)
JP2009542702A5 (https=)
JP2017505293A5 (https=)
JP2011516428A5 (https=)
RU2013155586A (ru) [1,3]оксазины
JP2015524472A5 (https=)
JP2012530779A5 (https=)
JP2016534124A5 (https=)
JP2016505637A5 (https=)
JP2014528464A5 (https=)
EA201270144A1 (ru) Комбинированная терапия при лечении диабета